Fabienne Schochter

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Ignace Vergote, José Alejandro Pérez Fidalgo, Erika Hamilton et al. · Journal of Clinical Oncology · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial

Bernadette Jaeger, Jörg Neugebauer, U Andergassen et al. · PLoS ONE · 2017 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +16

Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program

Amelie Schramm, Thomas W. P. Friedl, Fabienne Schochter et al. · Archives of Gynecology and Obstetrics · 2015 · 49 citations

Medicine, Cancer Biology, Oncology +17

Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients

André Franken, Ellen Honisch, F Reinhardt et al. · Journal of Molecular Diagnostics · 2019 · 37 citations

Medicine, Cancer Biology, Oncology +17